New Treatments Available For Those With Aids

New Treatments Available For Those With Aids



AIDS is​ a​ fatal illness that affects the​ immune system. it​ accounts for​ millions of​ deaths each year and​ is​ a​ serious worldwide epidemic. Over forty million people in​ the​ world are infected with AIDS. the​ immune system degenerates, making those infected susceptible to​ infection and​ disease. Over three million people died of​ this disease in​ 2018. There is​ no cure for​ AIDS but there are treatments available to​ help slow the​ progression. AIDS is​ researched throughout the​ world in​ order to​ discover new treatments to​ prolong life and​ to​ find a​ cure. Currently, there have been studies on two new drugs that show promising results.

Merck & Co., a​ drug manufacturer in​ New Jersey, conducted clinical trials on a​ new pill. it​ is​ to​ be taken orally twice per day to​ help slow the​ progression of​ the​ disease. Studies indicated this drug is​ performing better than the​ other medications currently on the​ market. This drug will be especially beneficial to​ long term AIDS sufferers who have developed a​ resistance to​ pharmaceuticals existing today.

The studies were performed on 167 patients who have shown progression of​ the​ disease and​ have critically impaired health. Many of​ these patients have taken the​ drug AZT, a​ common treatment, for​ more than ten years. in​ the​ clinical trials, varying doses of​ the​ drug were experimented on with patients with varying conditions. in​ the​ most successful group, seventy two percent of​ the​ patients showed an​ improvement with virus levels becoming undetectable. in​ the​ least successful group, virus levels were reduced to​ undetectable amounts in​ fifty six percent. the​ results of​ the​ clinical trial were surprising but welcomed. the​ effects were astounding and​ the​ drug manufacturer is​ hopeful that it​ will help prolong the​ lives of​ people with AIDS. They are continuing to​ conduct research in​ larger trials and​ hope to​ apply for​ approval from the​ Food and​ Drug Administration in​ 2018.

Gilead Sciences, a​ competing drug manufacturer, also showed positive results from a​ similar type drug. Although the​ clinical trials were much smaller then Merck’s, the​ company is​ hopeful the​ results will set the​ stage for​ larger trials. the​ drug is​ called an​ integrase inhibitor. Integrase is​ an​ enzyme that speeds the​ progression of​ HIV. the​ inhibitor blocks the​ enzyme, slowing this process. the​ initial trials were only conducted with only ten patients. However, after ten days there was a​ one hundred fold reduction in​ virus levels. Similar to​ the​ Merck study, this shows promise in​ helping to​ prolong the​ life of​ patients. This pill will be taken once per day in​ conjunction with Novir, another AIDS medication. Increased studies of​ this drug will begin in​ the​ spring of​ 2018.

Although AIDS is​ a​ world wide epidemic with no cure as​ of​ yet, continuing research is​ showing promise. Recent studies indicate there will soon be two new drugs available for​ treatment, both showing incredibly enhanced improvement from existing medications. as​ science advances, scientists are hopeful that they will one day find a​ cure for​ this disease, eradicating it​ from existence.




You Might Also Like:




No comments:

Powered by Blogger.